Back to search

Institutional Repository of Vilnius University

C-MYC ir CTNNB1 diagnostinės ir prognostinės vertės nustatymas šviesių ląstelių inkstų karcinomos pacientų kraujo plazmoje /

Abstract

dc:description

Clear cell Renal Cell Carcinoma (ccRCC) is the most diagnosed type of renal cell carcinoma. ccRCC is often diagnosed in late stages of cancer due to the absence of symptoms in the early stages. Recent data show that Lithuania has the highest incidence rates of ccRCC compared to other countries. This encourages the research of new alternative diagnostic methods to the traditional invasive tissue biopsy, which can be performed without the risk of complications and can detect changes in the patient's body at an earlier stage. This would allow earlier diagnosis of the disease and initiation of treatment, which would increase the survival rate of patients with kidney cancer. Liquid biopsy, which is being rapidly researched and increasingly used in diagnostics, can provide information about changes in the body in real time. For example, the amount of messenger RNA (mRNA) detected in blood plasma samples provides information about the expression of altered genes in the body. In this study two signaling pathways were analyzed, Wnt and Myc, which are dysregulated in different types of cancer, leading to rapid cell growth and cancer development. The Wnt pathway is mainly mediated by the gene encoding the β-catenin protein (CTNNB1), while the Myc pathway is mediated by the MYC proto-oncogene (C-MYC). Due to the heterogeneity of ccRCC, there are still no validated genetic biomarkers to diagnose the disease from liquid biopsy, although many candidate genes have been identified. There-fore, changes in C-MYC and CTNNB1 gene expression in liquid plasma biopsies from ccRCC patients provide information on their potential and efficacy as genetic biomarkers for disease detection. The study showed a moderate performance of C-MYC and CTNNB1 genes in the diagnosis of ccRCC. C-MYC gene expression was statistically significantly different between ccRCC and angiomyolipoma samples (p = 0.04). There was a correlation of C-MYC with the age of ccRCC patients. Although CTNNB1 gene expression did not differ between control benign kidney tumor samples, there was a trend toward significance correlation between tumor diameter and gene expression in ccRCC patients. ROC analysis showed that the genes work better together than alone and an AUC value of 0.71 was found to distinguish ccRCC from oncocytomas or angiomyolipomas.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Urbonaitė, Milda,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Urbonaitė, Milda,. C-MYC ir CTNNB1 diagnostinės ir prognostinės vertės nustatymas šviesių ląstelių inkstų karcinomos pacientų kraujo plazmoje /. Institutional Repository of Vilnius University, 2025. https://repository.vu.lt/VU:ELABAETD239024371&prefLang=en_US